Search

Search Constraints

You searched for: Author/Creator Park, D I

Search Results

1. DOP67 Comparison of the pharmacokinetics of CT-P13 between Crohn's Disease and Ulcerative Colitis in biologic-naïve patients; a prospective multi-center observational study of the KASID. (27th May 2021)

2. OP024 Long-term safety and efficacy of the anti-MAdCAM monoclonal antibody SHP647 for the treatment of Crohn's disease: the OPERA II study. (16th January 2018)

3. OP08 Long-term efficacy and pharmacodynamics of the anti-mucosal addressin cell adhesion molecule-1 (MAdCAM-1) monoclonal antibody SHP647 in Crohn's disease: the OPERA II study. (25th January 2019)

4. P144 Changes of fecal metabolic and lipidomic features by anti-tumor necrosis factor treatment and prediction of clinical remission in patients with ulcerative colitis. (21st January 2022)

5. P266 Potential oral microbial markers for differential diagnosis of Crohn's disease and ulcerative colitis using machine learning model. (30th January 2023)

6. P272 Predictors of health-related quality of life in patients with newly diagnosed moderate to severe ulcerative colitis: Results from the MOSAIC cohort in Korea. (16th January 2018)

7. P290 Development of an artificial intelligence model using stool pictures for predicting endoscopic mucosal inflammation in patients with Ulcerative Colitis; KASID multicenter study. (30th January 2023)

8. P333 The baseline features of patients with newly diagnosed moderate-to-severe ulcerative colitis in Korea: A population-based cohort study (the MOSAIK cohort). (16th January 2018)

9. P348 Clinical outcomes and response predictors of vedolizumab treatment for anti-TNF-failed patients with IBD in Korea: A prospective multicenter cohort study. (15th January 2020)

10. P477 The efficacy of adalimumab for the treatment of Korean patients with ulcerative colitis and predictors of response: Preliminary results. (16th January 2018)